Banach M, Patti AM, Giglio RV, Cicero AFG, Bajraktari G, Brucker E, Descamps O, Djuric D, Ezhov M, Fras Z, von Haehling S (2018). The role of nutraceuticals in statin intolerant patients. Journal of the America College of Cardiology 72(1):96-118
Crossref

Food and Drug Administration (FDA) (2016). Labeling and Nutrition. Food and Drug Administration, US Department of Health and Human Services. 5 October 2016. Retrieved 21 Nov 2020

Gupta S, Yadav AK (2022). Emerging trend of chondroitin sulfate in nanoparticles preparation, targeting, and pharmaceutical applications. Polysaccharide Nanoparticles pp. 65-90.
Crossref

Kaplan S (2019). Supplement makers touting cures for Alzheimer's and other diseases get FDA warning. New York Times, 11 February 2019. Retrieved 21 Nov 2020

Lockwood GB (2015). Quality evaluation and safety of commercially available nutraceutical and formulated products. In: Nutraceutical and Functional Processing Technology (pp. 113-150).
Crossref

Melia CD, Davis SS (1989). Mechanisms of drug release from tablets and capsules. I: disintegration. Alimentary Pharmacology and Therapeutics 3(3):223-232.
Crossref

Rawat S, Derle DV, Fukte SR, Shinde PR, Parve BS (2014). Superdisintegrants: an overview. World Journal of Pharmacy and Pharmaceutical Sciences 3(5):263-278.

Russell AS, Aghazadeh-Habash, A, Jamali F (2002). Active ingredient consistency of commercially available glucosamine sulfate products. The Journal of Rheumatology 29(11):2407-2409.

Sarris J, Murphy J, Mischoulon D, Papakostas GI, Fava M, Berk M, Ng CH (2016). Adjunctive nutraceuticals for depression: A systematic review and meta-nalysis. American Journal of Psychiatry 173(6):575-587.
Crossref

Verma K, Sharma PK, Dudhe R, Patro ASK (2014). Formulation, design and development of Mifepristone immediate release tablet. International Journal of Pharma Sciences and Research 5(11):760-769.